With a pack of Genentech Inc. veterans, SARcode has moved its drug, called lifitegrast, from South San Francisco's Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) into the two studies, including one ...

The acquisition of SARcode, a privately-held, venture-backed biopharmaceutical in Brisbane, Calif. founded in 2006, comes just a little over a week after Shire acquired Premacure, a Swedish ...

As part of the license agreement, Sunesis has earned a milestone paymentfrom SARcode of $500,000 and a $375,000 convertible note. The next payablemilestone, if earned, will be for initiation of ...

Ora and SARcode's parent company, Shire, look forward to exploring opportunities that may arise to work together in the future. SARcode Biosciences Inc. is a wholly-owned subsidiary of Shire.

Investors are less enthusiastic. In response to today's news, Shire shares fell 0.1% to close at $90.61. The article Shire Buying SARcode for $160 Million originally appeared on Fool.com. Fool ...

Shire will pay SARcode Bioscience $160 million up-front, plus additional payments to be received by SARcode shareholders tied to achieving undisclosed clinical, regulatory, and/or commercial ...

Quinton C. Oswald can be reached at SARcode Biosciences, 1000 Marina Blvd., Suite 250, Brisbane, CA 94005; 650-416-7563; fax: 650-588-5330; email: [email protected].

SARcode Bioscience, Inc., a privately held biopharmaceutical company based in Brisbane, California, has reported topline results from OPUS-1, a pivotal phase 3 study of lifitegrast ophthalmic solution ...

Investors are less enthusiastic. In response to today's news, Shire shares fell 0.1% to close at $90.61. The article Shire Buying SARcode for $160 Million originally appeared on Fool.com. Fool ...

Under the agreement, SARcode has paid Sunesis a $500,000 milestone payment as well as a $375,000 convertible note. The next payable milestone would be for initiation of a phase 2 clinical program ...

Investors are less enthusiastic. In response to today's news, Shire shares fell 0.1% to close at $90.61. The article Shire Buying SARcode for $160 Million originally appeared on Fool.com. Fool ...